Woodcasting Versus Thermoplast Splint in CMC Arthroplasty

Last updated: March 13, 2025
Sponsor: Foundation for Orthopaedic Research and Education
Overall Status: Active - Recruiting

Phase

N/A

Condition

Joint Injuries

Treatment

Control (Standard treatment)

Woodcasting Splint

Clinical Study ID

NCT06876350
Study007574
  • Ages > 18
  • All Genders

Study Summary

This study is a prospective, randomized, nonblinded trial to evaluate patient preference in splints after having a carpometacarpal arthroplasty.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients over the age of 18 years old.

  • Intact Medical Decision Making

  • Eligible for Surgical Intervention

  • Willing to comply with all aspects of the treatment and evaluation schedule over 6weeks

Exclusion

Exclusion Criteria:

  • Pregnant Women

  • Deemed Unsuitable by Principal Investigator

Study Design

Total Participants: 26
Treatment Group(s): 2
Primary Treatment: Control (Standard treatment)
Phase:
Study Start date:
October 03, 2024
Estimated Completion Date:
June 30, 2025

Study Description

Patients undergoing carpometacarpal arthroplasty will be randomized into the woodcast or thermoplast splint after their surgery to see which is preferred using compliance and surveys.

Connect with a study center

  • Florida Orthopaedic Institute

    Tampa, Florida 33637
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.